China, Manufacturing, Industrial policy

China's dominance is nuts

This is not just happening in the automotive industry. In biotech, western pharmaceutical companies are signing billions of dollars in licensing deals to access intellectual property from Chinese drugmakers, reaching $41.5bn in 2024. In robotics, American start-ups are building with Chinese hardware platforms, such as Unitree’s nimble G1 humanoid robot. In AI, Chinese open-source models such as Alibaba’s Qwen series are being…